1 / 1

Names: Andrew Jin and Steven Wang High School: The Harker School, San Jose, CA

Names: Andrew Jin and Steven Wang High School: The Harker School, San Jose, CA Mentor: Dr. Dobrin Draganov

tegan
Download Presentation

Names: Andrew Jin and Steven Wang High School: The Harker School, San Jose, CA

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Names: Andrew Jin and Steven Wang High School: The Harker School, San Jose, CA Mentor: Dr. DobrinDraganov Project Title: Rational Discovery and Optimization of Synergistic Chemotherapy Combinations: A Novel Framework Integrating Gene Perturbation Analysis and Machine Learning Algorithms Although the failure of single-targeted chemotherapy agents is inevitable, recent studies demonstrate that combinatorial dual therapy can effectively treat most cancers. However, two major obstacles hinder current multi-component drug design efforts: trial-and-error screening methods are too expensive and time-consuming to be practical, and the majority of identified combinations are too toxic for clinical application. In this study, we created a novel interdisciplinary approach integrating gene expression perturbation models, artificial neural networks (ANN), and in vitro experimentation to rationally guide and accelerate the discovery of synergistic drug pairs. By computationally screening databases of drug-associated perturbation profiles, we discovered and experimentally validated four dual therapies (three of which are novel) that synergize by knocking down resistance-associated genes and activating sensitivity-associated genes. The doxorubicin-adiphenine combination exhibited especially potent synergy, almost doubling the effect of doxorubicin while keeping toxicity constant. Furthermore, we created an ANN (86.7% classification accuracy, 100% sensitivity, and 85.2% specificity) using molecular and protein target characteristics to accurately predict a second type of drug combinations that synergize through complementary pathway mechanisms. Since synergistic dual therapies offer increased anti-proliferative effects, reduced toxicity, and prevention of drug resistance, our interdisciplinary framework is a valuable tool for future combinatorial treatment design efforts.

More Related